Status | Study |
Completed |
Study Name: A Retrospective Study Evaluating the Efficacy and Safety of Micafungin Sodium in the Treatment of Invasive Fungal Infections Condition: Invasive Fungal Infections Date: 2016-02-02 Interventions: Drug: Micafungin Intravenous |
Completed |
Study Name: Evaluation of the Potential for Cytochrome P450 3A4 Inhibition by F901318 Using Oral Midazolam as a Probe Condition: Invasive Aspergillosis Date: 2016-01-28 Interventions: Drug: Midazolam with F901318 Pharmacokinetics of midazolam with F901318 |
Terminated |
Study Name: Post Marketing Study to Evaluate the Efficacy and Safety of Micafungin Treatment on Invasive Aspergillosis Condition: Invasive Aspergillosis Date: 2015-12-16 Interventions: Drug: Micafungin Injection |
Terminated |
Study Name: Post Marketing Study to Evaluate the Safety and Efficacy of Micafungin Against Fungal Infections Caused by Candida Spp or Aspergillus Spp Condition: Candidiasis Aspergillosis Date: 2015-12-16 Interventions: Drug: Micafungin Injection |
Recruiting |
Study Name: A Randomized Trial of Itraconazole in Acute Stages of Allergic Bronchopulmonary Aspergillosis Condition: Allergic Bronchopulmonary Aspergillosis Date: 2015-05-01 Interventions: Drug: Itraconazole Oral itraco |
Terminated |
Study Name: Concentrations of Voriconazole in Blood and BAL-fluid After Inhalation and Oral Administration Condition: Invasive Aspergillosis Date: 2015-03-18 Interventions: Drug: Voriconazole |
Completed |
Study Name: Single Ascending Oral Dose Study of F901318 Condition: Invasive Aspergillosis Date: 2015-03-16 Interventions: Drug: F901318 safety Safety as |
Completed |
Study Name: F901318 Multiple Ascending Dose Study Condition: Invasive Aspergillosis Date: 2015-01-15 Interventions: Drug: F901318 Administration o |
Enrolling by invitation |
Study Name: Evaluation of a Therapeutic Strategy Including Nebulised Liposomal Amphotericin B (Ambisome®) in Maintenance Treatment of Allergic Bronchopulmonary Aspergillosis (Cystic Fibrosis Excluded). Condition: Allergic Bronchopulmonary Aspergillosis Date: 2014-10-22 Interventions: Drug: Liposomal amphotericin B (Ambisome®) |
Enrolling by invitation |
Study Name: Voriconazole for IPA in Chinese Patients With COPD Condition: Invasive Pulmonary Aspergillosis COPD Date: 2014-09-02 Interventions: Drug: Voriconazole 2-week long intravenous instillation of voriconazole |